MedPath

Observation of Microvessels and Invasion in Early Colorectal Lesions by NBI

Completed
Conditions
Colorectal Neoplasms
Registration Number
NCT02047188
Lead Sponsor
Xiaobo Li
Brief Summary

Combined with magnifying endoscopy,narrow-band imaging (NBI) contrasts microvascular architecture on lesion surface.The histology of early colorectal lesions could be predicted under NBI view.However,its capability for estimating invasion depth remains to be verified.The study is based on the hypothesis:NBI can predict histology and invasion depth,combined with the verification of microvessel count and MMP-7 expression.

Detailed Description

The microvessel count (MVC) is a classical method of assessing histologic grade.To verify whether NBI could predict histology through microvascular architecture,we measured lesion microvessels by immunohistochemistry.On the other hand,we applied immunohistochemistry of matrix metalloproteinase-7 (MMP-7) to validate the capability of NBI for estimating invasion depth.MMP-7 is directly involved in the processes of growth, invasion, and metastasis of colorectal cancer.Our target was to clarify the diagnostic accuracy of magnifying NBI in early colorectal lesions,combined with the verification of microvessel count and MMP-7 expression.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
418
Inclusion Criteria
  • patients of early colorectal lesions with capillary pattern(CP) type II&III,initially detected by white-light view and then examined by NBI with magnifying endoscopy.
Exclusion Criteria
  • lesions with CP type I;
  • CP type III lesions with an obvious appearance of advanced cancer;
  • lesions that had underwent biopsy;
  • patients with inflammatory bowel disease(IBD) or familial adenomatous polyposis(FAP)
  • patients with previous colorectal surgery;
  • having conditions associated with cardiac,hepatic,renal,and coagulopathy diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
NBI prediction for lesion histology and invasionin two weeks after lesion treatment

We will receive the histologic findings in two weeks after lesion treatment.Then we can compare NBI prediction with the final histologic type.

Secondary Outcome Measures
NameTimeMethod
immunohistochemical outcome of microvessel count and MMP-7in three days after immunohistochemistry

We will receive the immunohistochemical outcome in three days after immunohistochemistry.Then we can compare NBI prediction with immunohistochemical outcome

© Copyright 2025. All Rights Reserved by MedPath